Immatics (IMTX) Income from Non-Controlling Interests (2019 - 2021)

Immatics (IMTX) reported Income from Non-Controlling Interests of -$33.6 million for Q2 2021, down 10692.4% on a YoY basis from N/an in Q2 2020, and down 10692.4% sequentially from -$311713.2 in Q2 2020.

Immatics (IMTX) Income from Non-Controlling Interests (2019 - 2021) Analysis & Trends

Immatics (IMTX) has 3 years of Income from Non-Controlling Interests data on file, last reported at -$33.6 million in Q2 2021.

  • For the quarter ending Q2 2021, Income from Non-Controlling Interests fell 10692.4% year-over-year to -$33.6 million; the trailing twelve-month figure through Mar 2024 stood at -$311713.2 (changed N/A YoY), and the FY2020 full-year result was -$635968.0, up 38.01% from the prior year.
  • Income from Non-Controlling Interests slipped to -$33.6 million in Q2 2021, from -$311713.2 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$249049.7 in Q4 2019 to a low of -$33.6 million in Q2 2021.
  • A 3-year average of -$5.8 million and a median of -$297007.3 in 2019 frame the typical range for Income from Non-Controlling Interests.
  • Across the five-year window, Income from Non-Controlling Interests dropped 19.58% in 2020 and plunged 10692.4% in 2021, its largest moves.
  • Tracing IMTX's Income from Non-Controlling Interests over 3 years: stood at -$249049.7 in 2019, then decreased by 25.16% to -$311713.2 in 2020, then sank by 10692.4% to -$33.6 million in 2021.
  • Business Quant data shows IMTX's Income from Non-Controlling Interests at -$33.6 million in Q2 2021, -$311713.2 in Q2 2020, and -$302479.3 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Immatics 1.11 Bn 1.11 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -33.64 Mn
Jun 30, 2020 -311,713.22
Mar 31, 2020 -302,479.29
Dec 31, 2019 -249,049.73
Sep 30, 2019 -291,535.27
Jun 30, 2019 -260,684.27